UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
Abstract Background Metabolic disturbance is a hallmark of cancers. Targeting key metabolic pathways and metabolism‐related molecular could be a potential therapeutic approach. Uncoupling protein 2 (UCP2) plays a pivotal part in the malignancy of cancer and its capacity to develop resistance to phar...
| Published in: | Cancer Medicine |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.6938 |
